24-month randomized controlled clinical trial assessment of surface texture, color stability, and marginal discoloration of sonic activated bulk-fill resin composite according to USPHS and FDI criteria

TL;DR

This study compared two types of bulk-fill resin composites over 24 months and found no significant differences in their performance.

Contribution

The study provides long-term clinical data on sonic-activated and non-sonic-activated bulk-fill resin composites.

Findings

Both BFRCs showed clinically successful outcomes over 24 months.

No significant differences were found between sonic-activated and non-sonic-activated BFRCs.

USPHS and FDI criteria were reliable and comparable for evaluating restorations.

Abstract

To assess the surface texture, color stability, and marginal discoloration of sonic-activated bulk-fill resin composite (BFRC) in comparison to non-sonic-activated BFRC, over 24 months, by two different evaluation criteria.

30 adult patients, each presented with at least two carious lesions, either Class I or Class II cavities in their posterior teeth, were selected and subdivided randomly into two identical groups: one group restored with Sonicfill 3 and the other group restored with the X-tra fill, with total of 60 restorations for both groups. Surface texture, color stability, and marginal discoloration were assessed at baseline (1 week), then at 3, 6, 12, and 24-month periods, applying the modified United States Public Health Services (USPHS) criteria and World Dental Federation (FDI) criteria.

After the 24-month follow-up evaluation period, there was a non-significant difference in the clinical outcomes between both tested groups, with a non-statistical difference between the results’ outcomes evaluated by USPHS or FDI criteria, where all restorations were considered clinically successful by both criteria.

The surface texture, color stability, and marginal discoloration of both tested BFRCs over 24 months were considered clinically successful, either with or without the use of sonic energy. Regarding both criteria, they were reliable, comparable, and suitable for evaluating the clinical performance of RC restorations.

The current study underwent registration at www.clinicaltrials.gov and obtained the unique identification number NCT04926883 for its protocol on 03/06/2021.

Figures